Announced
Completed
Sequoia Capital China led a $232m series F funding round in Miaoshou Doctor.
Financials
Transaction Value£203m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-
Sources
Tags
Acquisition
Private Equity
Domestic
Private
Minority
China
Friendly
Single Bidder
pharmaceuticals
pharmaceutical e-commerce
E-commerce
Completed
Synopsis
Sequoia Capital China, a VC firm, led a $232m series F funding round in Miaoshou Doctor, a healthcare service platform, with participation from Springhill, B Capital Group, Hel Ved Capital, Orbimed, UOB Venture, Efund and Index Capital.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.